Table 2.
Age, PRETEXT Classification, Histology, Treatment, and Time to Relapse for the 25 Relapse Patients.
| Pat. No. | Age (m) |
PRETEXT | Histology | Chemo | Surgery | Time Dx to Relapse (m) |
|---|---|---|---|---|---|---|
| 1 (D) | 104 | III N+ | HB (DD HCC) | Carbo, Etop, Cis, Dox, Ifo | (1) Liver (R1) | 19 |
| 2 (D) | 36 | III M+ | HB | Carbo, Etop, Melp | (1) Liver (R0), (2) Lung (MD), (3) Lung (R0) | 33 |
| 3 (A) | 16 | III M+F+ | HB | Carbo, Etop | (1) Liver (R0) (+Lung—NAD) | 22 |
| 4 (D) | 4 | IV M+E+ | HB | Cis, Dox, Ifo, Carbo, Etop, Ir | (1) Liver (R0), (2) Lung (MD) | 7 |
| 5 (A) | 26 | III M+ | HB | Cis, Do, Ifo, Carbo, Etop | (1) Liver (R0), (2) Lung R + L (R0) | 19 |
| 6 (D) | 13 | IV M+ | HB | Cis, Dox, Ifo, Carbo, Etop | (1) Liver (R0) | 8 |
| 7 (D) | 3 | III R+ | SCUD (INI1 MD) |
Cis, Dox, Ifo | (1) Liver (R1) | 9 |
| 8 (A) | 10 | IV R+F+ | HB | Carbo, Etop | (1) Liver (R0) | 7 |
| 9 (A) | 12 | II | HB | Cis, Dox, Ifo | (1) Liver (R0) | 21 |
| 10 (D) | 117 | II R+ | HB (DD HCC) | Cis, Dox, Ifo | (1) Liver (R0) | 45 |
| 11 (D) | 53 | IV M+P+ | HB (DD HCC) | Carbo, Etop | (1) Liver (R1), (2) Lung (R0), (3) Lung (R0) | 12 |
| 12 (A) | 158 | II P+ | HB (Macrotrab) | Cis, Dox, Ifo | (1) Liver (R0) | 21 |
| 13 (D) | 40 | III | HB | Cis | (1) Liver (R0) | 5 |
| 14 (A) | 18 | I M+E+ | HB | Cis, Carbo, Dox, Etop, Ifo, Vin, Ir | (1) Liver (R0), (2) Lung (R1), (3) Lung (R0) | 66 |
| 15 (A) | 23 | III M+P+ | HB | Cis, Carbo, Dox | (1) Liver (R1) | 13 |
| 16 (D) | 24 | II | HB | Cis, 5-FU, Vin | (1) Liver (R0) | 10 |
| 17 (A) | 94 | IV M+F+ | HB | Cis, Carbo, Dox | (1) Liver (R0) | 21 |
| 18 (D) | 35 | IV P+F+ | HB | Cis, Carbo, Dox | (1) LTx (R1) | 10 |
| 19 (D) | 21 | III V+P+F+ | HB | Cis, Carbo, Dox | (1) Liver (R0), (2) Lung (R0) | 8 |
| 20 (A) | 8 | II | HB | Cis | (1) Liver (R0) | 10 |
| 21 (A) | 15 | III | HB | Cis, Carbo, Dox, Vin, Ir | (1) Liver (R0), (2) Lung (R0), (3) Lung (R0) | 10 |
| 22 (A) | 29 | IV M+V+P+F+ | HB | Cis, Carbo, Dox, Vin, Ir, Ifo, Etop | (1) Lung R (MD) and L (R0), (2) LTx (R2) | 35 |
| 23 (A) | 75 | IV V+F+ | HB (DD HCC) | Cis, Carbo, Dox, Sor, Vin, Ir | (1) Liver (R1), (2) Lung (R1) | 12 |
| 24 (A) | 51 | IV F+ | HB/SCUD (INI1+) | Cis, Carbo, Dox | (1) Liver (R0) | 26 |
| 25 (D) | 4 | III V+ | HB | Cis, Carbo, Dox, Vin, Ir, Etop | (1) Liver (R2), (2) LTx (R0) | 13 |
A = alive, D = dead, MD = missing data, NAD = no abnormality detected, Pat. = patient, PRETEXT = pre-treatment extent of disease, M+ = distant metastatic disease, V+ = venous invasion, P+ = portal vein invasion, E+ = extrahepatic intra-abdominal mets, R+ = tumor rupture, F+ = multi-focal, N+ = lymph node mets, Cis = cisplatin, Carbo = carboplatin, Etop = etoposide, Dox = doxorubicin, Melp = melphalan, Ifo = ifosfomide, Vin = vincristine, Ir = irinotecan, 5-FU = 5-fluorouracil, Sor = sorafenib, R0 = microscopically complete resection, R1 = microscopically positive resection, R2 = macroscopically positive resection, Dx = diagnosis, m = months, LTx = liver transplant.